An Investor’s Guide to Moderna Stock by Money and Markets Staff | Jan 18, 2023 | Investing COVID-19 introduced a race for a vaccine, but how does Moderna stock (Nasdaq: MRNA) rate now that the pandemic is ...
No. 1 Investing Takeaway for the Midterm Elections by Adam O'Dell | Nov 7, 2022 | Investing Midterm elections will change the political landscape in the U.S. But what about investment portfolios? Here's our top post-election tips.
A Mega Trend With Recession-Fighting Power by Adam O'Dell | Oct 17, 2022 | Investing It's prudent to prepare for a recession now. When investing, that means targeting opportunities such as this health care mega ...
“Strong Bullish” Biopharma Stock Rips 130% Higher — and It’s Not Done by Matthew Clark | Aug 16, 2022 | Investing DVAX is a biopharma stock with promise as the company develops its signature hepatitis B vaccine. Here's why it's a ...
Be a Biotech Value Investor (Start With 2 Stocks!) by Adam O'Dell | Feb 21, 2022 | Investing Do you want to be a biotech value investor? It's possible to target solid companies trading at cheaper valuations in ...
Genomics’ Future Is Bright (2021 Market Reflections) by Adam O'Dell | Dec 27, 2021 | Investing The biotech sector struggled in 2021, but the future is bright. The genomics mega trend will create life-changing wealth in ...
Beyond 2022: Invest in 5 Mega Trends for Multiyear Profits by Adam O'Dell | Dec 23, 2021 | Investing Stock market mega trends are everywhere, but some are better than others. Here are five that should provide years of ...
3 Market Mega Trends for 2022 and Beyond by Adam O'Dell | Dec 10, 2021 | Investing There are plenty of market mega trends to track in 2022. Here are three that chief investment strategist Adam O'Dell ...
COVID Trade Is Dead: Genomics Is Ready for the Spotlight by Adam O'Dell | Nov 12, 2021 | Investing COVID-19 may not be a reliable investing theme anymore, but it opened the door for the biggest stock mega trend ...
Biotech IPO Buzz: Here’s the Best Way to Play It by Adam O'Dell | Oct 11, 2021 | Investing The genomics and biotech revolution is here. Read this before you add a biotech IPO (initial public offering) to your ...